More on EBS
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $5.87 |
|
|||
| Open | $5.98 | ||||
| 52 Wk High | $44.38 | ||||
| 52 Wk Low | $24.47 | ||||
| Day High | $6.39 | ||||
| Day Low | $5.88 | ||||
| P/E | 311.00 | ||||
| EPS | $0.02 | ||||
| Volume | 989,562 | ||||
- Emergent BioSolutions buys back $75M in senior unsecured notes
- Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes
- Form 8-K Emergent BioSolutions For: Aug 18
- Emergent BioSolutions gets $24M BARDA contract for anthrax vaccine
- Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
- Emergent BioSolutions wins Canada NARCAN supply deal through 2029
- Emergent BioSolutions Awarded Government of Canada Standing Offer for NARCAN® Nasal Spray
- Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day
- JPMorgan Reinstates Emergent BioSolutions (EBS) at Underweight
- Form SCHEDULE 13G Emergent BioSolutions Filed by: AMERICAN CENTURY INVESTMENT MANAGEMENT INC
Entities mentioned with EBS
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- 13G | View Related Stories »
- Show More...
